Tianjin Medical University Cancer Institute And Hospital

This study tests a combination of chemotherapy, immunotherapy, and a targeted drug given directly into the liver's blood supply to shrink tumors in people with liver cancer that may be removable with surgery. The goal is to see if this approach can make surgery more effective and…

This study tests whether adding an immunotherapy drug (treprizumab) to standard chemotherapy before surgery can improve outcomes for people with advanced head and neck cancer. About 122 participants will be randomly assigned to receive either the drug combo or chemo alone for thr…

This study tests whether adding the drug surufatinib to standard chemotherapy can help shrink pancreatic tumors enough to allow successful surgery. It involves 29 adults with locally advanced or borderline resectable pancreatic cancer. The main goal is to see how many tumors can …

This study tests a combination of three drugs (oral etoposide, anlotinib, and envafolimab) as a first treatment for elderly patients with extensive small cell lung cancer. The goal is to see if this approach can delay cancer growth and improve survival. Thirty participants will r…

This study tests a combination of two drugs, cadonilimab and regorafenib, in 30 people with advanced liver cancer that has not responded to at least one prior treatment. The goal is to see if the combination can shrink tumors or slow cancer growth. Participants receive the drugs …

This early-stage trial tests a new treatment called GK01 cell injection combined with an immunotherapy drug (PD-1 antibody) in 15 adults with advanced solid tumors that have spread or come back. The main goal is to check safety and how the body handles the treatment, with early s…

This study tests a personalized, high-dose radiation therapy (SBRT) for people with early-stage peripheral non-small cell lung cancer who cannot have surgery or choose not to. The goal is to see if this tailored approach controls the tumor and helps patients live longer with fewe…

This study tests a combination of three drugs (fruquintinib, an immunotherapy, and an oral chemo) in people with advanced colorectal cancer that has stopped responding to standard treatments. About 106 participants will receive this new approach to see if it can shrink tumors and…

This study tests whether an artificial intelligence (AI) management program can reduce anxiety and depression in 300 women with HR+/HER2- breast cancer who are taking CDK4/6 inhibitor pills at home. Participants are randomly assigned to the AI model, a customized follow-up, or st…

This study looks back at medical records from 400 older adults (age 60+) with Hodgkin lymphoma in China. Researchers are collecting information on patient characteristics, treatments, and survival to build a model that can predict how the disease will progress. The goal is to hel…

This study looks at whether using a small camera to look inside the belly (laparoscopy) can help doctors choose the best treatment for people with stage III stomach cancer. About 968 patients will be randomly assigned to either get this extra staging or not. The goal is to see if…

This study reviews medical records from 300 adult cancer patients to see if the composition of the tumor environment influences how well antibody-based therapies work. Researchers will analyze tissue samples and blood markers to find patterns linked to treatment success. The goal…

This study looked back at the medical records of 800 adults with liver cancer that could not be removed by surgery. All patients were treated with lenvatinib, a targeted therapy, at six hospitals. The goal was to see how long patients lived and how well the treatment worked in ev…